94 related articles for article (PubMed ID: 33798412)
1. Empowering MYC carcinogenesis via RNA loops.
Mays SG; Valcárcel J
Mol Cell; 2021 Apr; 81(7):1365-1367. PubMed ID: 33798412
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer.
Cieśla M; Ngoc PCT; Cordero E; Martinez ÁS; Morsing M; Muthukumar S; Beneventi G; Madej M; Munita R; Jönsson T; Lövgren K; Ebbesson A; Nodin B; Hedenfalk I; Jirström K; Vallon-Christersson J; Honeth G; Staaf J; Incarnato D; Pietras K; Bosch A; Bellodi C
Mol Cell; 2021 Apr; 81(7):1453-1468.e12. PubMed ID: 33662273
[TBL] [Abstract][Full Text] [Related]
3. The spliceosome, a potential Achilles heel of MYC-driven tumors.
Anczuków O; Krainer AR
Genome Med; 2015 Oct; 7():107. PubMed ID: 26490253
[TBL] [Abstract][Full Text] [Related]
4. MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors.
Urbanski L; Brugiolo M; Park S; Angarola BL; Leclair NK; Yurieva M; Palmer P; Sahu SK; Anczuków O
Cell Rep; 2022 Nov; 41(8):111704. PubMed ID: 36417849
[TBL] [Abstract][Full Text] [Related]
5. MYC-driven regulation of long non-coding RNA profiles in breast cancer cells.
Tokgun PE; Tokgun O; Kurt S; Tomatir AG; Akca H
Gene; 2019 Sep; 714():143955. PubMed ID: 31326549
[TBL] [Abstract][Full Text] [Related]
6. Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming.
Hirsch CL; Coban Akdemir Z; Wang L; Jayakumaran G; Trcka D; Weiss A; Hernandez JJ; Pan Q; Han H; Xu X; Xia Z; Salinger AP; Wilson M; Vizeacoumar F; Datti A; Li W; Cooney AJ; Barton MC; Blencowe BJ; Wrana JL; Dent SY
Genes Dev; 2015 Apr; 29(8):803-16. PubMed ID: 25877919
[TBL] [Abstract][Full Text] [Related]
7. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.
Zhang C; Xu B; Lu S; Zhao Y; Liu P
Mol Cancer; 2017 May; 16(1):90. PubMed ID: 28490334
[TBL] [Abstract][Full Text] [Related]
8. c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on breast cancer cell proliferation via inhibiting P53.
Zhu P; Li Y; Li P; Zhang Y; Wang X
Mol Genet Genomics; 2019 Oct; 294(5):1219-1229. PubMed ID: 31089812
[TBL] [Abstract][Full Text] [Related]
9. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.
Wang C; Yang Y; Zhang G; Li J; Wu X; Ma X; Shan G; Mei Y
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14620-14629. PubMed ID: 31262817
[TBL] [Abstract][Full Text] [Related]
12. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC.
Satoh K; Yachida S; Sugimoto M; Oshima M; Nakagawa T; Akamoto S; Tabata S; Saitoh K; Kato K; Sato S; Igarashi K; Aizawa Y; Kajino-Sakamoto R; Kojima Y; Fujishita T; Enomoto A; Hirayama A; Ishikawa T; Taketo MM; Kushida Y; Haba R; Okano K; Tomita M; Suzuki Y; Fukuda S; Aoki M; Soga T
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7697-E7706. PubMed ID: 28847964
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis.
Wilde BR; Ayer DE
Br J Cancer; 2015 Dec; 113(11):1529-33. PubMed ID: 26469830
[TBL] [Abstract][Full Text] [Related]
14. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
[TBL] [Abstract][Full Text] [Related]
15. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc.
He J; Li F; Zhou Y; Hou X; Liu S; Li X; Zhang Y; Jing X; Yang L
Cancer Lett; 2020 Jan; 469():419-428. PubMed ID: 31734356
[TBL] [Abstract][Full Text] [Related]
16. p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.
Olivero CE; Martínez-Terroba E; Zimmer J; Liao C; Tesfaye E; Hooshdaran N; Schofield JA; Bendor J; Fang D; Simon MD; Zamudio JR; Dimitrova N
Mol Cell; 2020 Feb; 77(4):761-774.e8. PubMed ID: 31973890
[TBL] [Abstract][Full Text] [Related]
17. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
[TBL] [Abstract][Full Text] [Related]
18. MYC-induced metabolic stress and tumorigenesis.
Wolpaw AJ; Dang CV
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):43-50. PubMed ID: 29791870
[TBL] [Abstract][Full Text] [Related]
19. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
[TBL] [Abstract][Full Text] [Related]
20. MYC as a driver of stochastic chromatin networks: implications for the fitness of cancer cells.
Sumida N; Sifakis EG; Kiani NA; Ronnegren AL; Scholz BA; Vestlund J; Gomez-Cabrero D; Tegner J; Göndör A; Ohlsson R
Nucleic Acids Res; 2020 Nov; 48(19):10867-10876. PubMed ID: 33051686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
